[424B5] AEye, Inc. Prospectus Supplement (Debt Securities)
AEye, Inc. (Nasdaq: LIDR) filed Amendment No. 4 to its 424(b)(5) prospectus, expanding its at-the-market (ATM) program with A.G.P./Alliance Global Partners from an aggregate $2.6 million to up to $75 million of common stock. The company has already issued about $23.7 million under prior supplements, leaving roughly $51.3 million available for future sales.
As of 25-Jul-2025, AEye’s public float is $129.7 million (29.28 M non-affiliate shares at $4.43), lifting it above the $75 million threshold; therefore, the Form S-3 I.B.6 limitations on incremental offerings no longer apply. The filing reiterates that AEye is an emerging growth and smaller reporting company and highlights the usual high-risk investment language.
The amendment increases capital-raising flexibility, potentially improving liquidity but also introducing dilution risk for existing shareholders as additional shares may be issued at market prices.
AEye, Inc. (Nasdaq: LIDR) ha presentato l'Emendamento n. 4 al suo prospetto 424(b)(5), ampliando il programma at-the-market (ATM) con A.G.P./Alliance Global Partners da un totale di 2,6 milioni di dollari fino a 75 milioni di dollari di azioni ordinarie. La società ha già emesso circa 23,7 milioni di dollari con i precedenti supplementi, lasciando circa 51,3 milioni di dollari disponibili per future vendite.
Al 25 luglio 2025, il flottante pubblico di AEye ammonta a 129,7 milioni di dollari (29,28 milioni di azioni non affiliate a 4,43 dollari ciascuna), superando la soglia di 75 milioni di dollari; di conseguenza, le limitazioni del modulo S-3 I.B.6 sulle offerte incrementali non si applicano più. Il documento ribadisce che AEye è una società in crescita emergente e con reporting ridotto, evidenziando il consueto linguaggio di investimento ad alto rischio.
L'emendamento aumenta la flessibilità nella raccolta di capitale, migliorando potenzialmente la liquidità ma introducendo anche un rischio di diluizione per gli azionisti esistenti, poiché potrebbero essere emesse ulteriori azioni a prezzi di mercato.
AEye, Inc. (Nasdaq: LIDR) presentó la Enmienda n.º 4 a su prospecto 424(b)(5), ampliando su programa at-the-market (ATM) con A.G.P./Alliance Global Partners de un total de 2,6 millones de dólares hasta 75 millones de dólares en acciones comunes. La compañía ya ha emitido aproximadamente 23,7 millones de dólares bajo suplementos anteriores, quedando disponibles cerca de 51,3 millones de dólares para futuras ventas.
Al 25 de julio de 2025, el flotante público de AEye es de 129,7 millones de dólares (29,28 millones de acciones no afiliadas a 4,43 dólares cada una), superando el umbral de 75 millones de dólares; por lo tanto, las limitaciones del Formulario S-3 I.B.6 sobre ofertas incrementales ya no aplican. La presentación reitera que AEye es una empresa emergente y de reporte reducido, destacando el habitual lenguaje de inversión de alto riesgo.
La enmienda aumenta la flexibilidad para recaudar capital, mejorando potencialmente la liquidez pero también introduciendo un riesgo de dilución para los accionistas existentes, ya que podrían emitirse acciones adicionales a precios de mercado.
AEye, Inc. (나스닥: LIDR)는 424(b)(5) 투자설명서에 대한 수정안 4호를 제출하여 A.G.P./Alliance Global Partners와의 시장가매출(ATM) 프로그램을 총 260만 달러에서 최대 7,500만 달러로 확대했습니다. 회사는 이전 보충서에서 약 2,370만 달러를 이미 발행했으며, 앞으로 약 5,130만 달러가 추가 판매를 위해 남아 있습니다.
2025년 7월 25일 기준으로 AEye의 공개 유통 주식 가치는 1억 2,970만 달러(비계열사 주식 2,928만 주, 주당 4.43달러)로, 7,500만 달러 기준을 넘어섰습니다. 따라서 Form S-3 I.B.6의 추가 증자 제한이 더 이상 적용되지 않습니다. 제출 문서는 AEye가 신생 성장 기업이자 소규모 보고 기업임을 재확인하며, 일반적인 고위험 투자 경고 문구를 강조합니다.
이번 수정안은 자본 조달의 유연성을 높여 유동성을 개선할 수 있지만, 추가 주식이 시장 가격으로 발행될 수 있어 기존 주주에게는 희석 위험을 초래할 수 있습니다.
AEye, Inc. (Nasdaq : LIDR) a déposé l'amendement n° 4 à son prospectus 424(b)(5), élargissant son programme at-the-market (ATM) avec A.G.P./Alliance Global Partners, passant d'un total de 2,6 millions de dollars à jusqu'à 75 millions de dollars d'actions ordinaires. La société a déjà émis environ 23,7 millions de dollars dans le cadre des suppléments précédents, laissant environ 51,3 millions de dollars disponibles pour de futures ventes.
Au 25 juillet 2025, le flottant public d'AEye s'élève à 129,7 millions de dollars (29,28 millions d'actions non affiliées à 4,43 dollars chacune), dépassant ainsi le seuil de 75 millions de dollars ; par conséquent, les limitations du formulaire S-3 I.B.6 sur les offres incrémentales ne s'appliquent plus. Le dépôt réaffirme qu'AEye est une entreprise en croissance émergente et une société à plus petite capitalisation, mettant en avant le langage habituel relatif aux investissements à haut risque.
L'amendement accroît la flexibilité de levée de fonds, améliorant potentiellement la liquidité mais introduisant également un risque de dilution pour les actionnaires existants, car des actions supplémentaires pourraient être émises au prix du marché.
AEye, Inc. (Nasdaq: LIDR) hat Änderungsantrag Nr. 4 zu seinem 424(b)(5)-Prospekt eingereicht und sein At-the-Market-(ATM)-Programm mit A.G.P./Alliance Global Partners von insgesamt 2,6 Millionen US-Dollar auf bis zu 75 Millionen US-Dollar an Stammaktien ausgeweitet. Das Unternehmen hat bereits etwa 23,7 Millionen US-Dollar unter vorherigen Nachträgen ausgegeben, wodurch noch rund 51,3 Millionen US-Dollar für zukünftige Verkäufe verfügbar sind.
Zum 25. Juli 2025 beträgt der öffentliche Streubesitz von AEye 129,7 Millionen US-Dollar (29,28 Mio. nicht verbundene Aktien zu je 4,43 USD), womit die Schwelle von 75 Millionen US-Dollar überschritten ist; daher gelten die Form S-3 I.B.6-Beschränkungen für zusätzliche Angebote nicht mehr. Die Einreichung bestätigt, dass AEye ein wachsendes, kleineres berichtspflichtiges Unternehmen ist und hebt die üblichen Hinweise auf hohe Investitionsrisiken hervor.
Die Änderung erhöht die Flexibilität bei der Kapitalbeschaffung, was die Liquidität potenziell verbessert, aber auch ein Verwässerungsrisiko für bestehende Aktionäre mit sich bringt, da zusätzliche Aktien zum Marktpreis ausgegeben werden können.
- Expanded ATM capacity to $75 M significantly increases fundraising flexibility without arranging a separate offering.
- Public float above $75 M removes Form S-3 I.B.6 issuance constraints, enabling larger, quicker capital raises.
- Potential dilution: remaining $51.3 M capacity could increase share count materially.
- High-risk designation reaffirmed; company still classified as emerging growth and smaller reporting, signaling earlier-stage risk profile.
Insights
TL;DR: Upsized ATM to $75M boosts capital access; dilution risk offsets benefit.
The jump from $2.6 M to $75 M materially widens AEye’s financing runway, signalling management’s intent to shore up liquidity without arranging a full underwritten deal. Surpassing the $75 M float threshold removes the 33% issuance cap, enabling faster execution if market conditions allow. While accretive to cash, issuing roughly 11.6 M new shares at the recent $4.43 quote would expand current share count by ~38%, pressuring EPS and potentially the stock price. Net effect: tactically positive for balance-sheet flexibility, strategically neutral-to-negative for per-share metrics.
TL;DR: Added fire-power helpful for liquidity; existing holders face dilution.
From an investor perspective, the enlarged ATM acts as an inexpensive insurance policy, letting AEye tap markets opportunistically. The company’s public float now exceeds $129 M, indicating improved market depth. However, absent clarity on use-of-proceeds or near-term cash needs, the market may discount the stock until visibility on capital deployment emerges. I view the amendment as impactful but balanced: access to funds is good, yet share overhang could cap upside.
AEye, Inc. (Nasdaq: LIDR) ha presentato l'Emendamento n. 4 al suo prospetto 424(b)(5), ampliando il programma at-the-market (ATM) con A.G.P./Alliance Global Partners da un totale di 2,6 milioni di dollari fino a 75 milioni di dollari di azioni ordinarie. La società ha già emesso circa 23,7 milioni di dollari con i precedenti supplementi, lasciando circa 51,3 milioni di dollari disponibili per future vendite.
Al 25 luglio 2025, il flottante pubblico di AEye ammonta a 129,7 milioni di dollari (29,28 milioni di azioni non affiliate a 4,43 dollari ciascuna), superando la soglia di 75 milioni di dollari; di conseguenza, le limitazioni del modulo S-3 I.B.6 sulle offerte incrementali non si applicano più. Il documento ribadisce che AEye è una società in crescita emergente e con reporting ridotto, evidenziando il consueto linguaggio di investimento ad alto rischio.
L'emendamento aumenta la flessibilità nella raccolta di capitale, migliorando potenzialmente la liquidità ma introducendo anche un rischio di diluizione per gli azionisti esistenti, poiché potrebbero essere emesse ulteriori azioni a prezzi di mercato.
AEye, Inc. (Nasdaq: LIDR) presentó la Enmienda n.º 4 a su prospecto 424(b)(5), ampliando su programa at-the-market (ATM) con A.G.P./Alliance Global Partners de un total de 2,6 millones de dólares hasta 75 millones de dólares en acciones comunes. La compañía ya ha emitido aproximadamente 23,7 millones de dólares bajo suplementos anteriores, quedando disponibles cerca de 51,3 millones de dólares para futuras ventas.
Al 25 de julio de 2025, el flotante público de AEye es de 129,7 millones de dólares (29,28 millones de acciones no afiliadas a 4,43 dólares cada una), superando el umbral de 75 millones de dólares; por lo tanto, las limitaciones del Formulario S-3 I.B.6 sobre ofertas incrementales ya no aplican. La presentación reitera que AEye es una empresa emergente y de reporte reducido, destacando el habitual lenguaje de inversión de alto riesgo.
La enmienda aumenta la flexibilidad para recaudar capital, mejorando potencialmente la liquidez pero también introduciendo un riesgo de dilución para los accionistas existentes, ya que podrían emitirse acciones adicionales a precios de mercado.
AEye, Inc. (나스닥: LIDR)는 424(b)(5) 투자설명서에 대한 수정안 4호를 제출하여 A.G.P./Alliance Global Partners와의 시장가매출(ATM) 프로그램을 총 260만 달러에서 최대 7,500만 달러로 확대했습니다. 회사는 이전 보충서에서 약 2,370만 달러를 이미 발행했으며, 앞으로 약 5,130만 달러가 추가 판매를 위해 남아 있습니다.
2025년 7월 25일 기준으로 AEye의 공개 유통 주식 가치는 1억 2,970만 달러(비계열사 주식 2,928만 주, 주당 4.43달러)로, 7,500만 달러 기준을 넘어섰습니다. 따라서 Form S-3 I.B.6의 추가 증자 제한이 더 이상 적용되지 않습니다. 제출 문서는 AEye가 신생 성장 기업이자 소규모 보고 기업임을 재확인하며, 일반적인 고위험 투자 경고 문구를 강조합니다.
이번 수정안은 자본 조달의 유연성을 높여 유동성을 개선할 수 있지만, 추가 주식이 시장 가격으로 발행될 수 있어 기존 주주에게는 희석 위험을 초래할 수 있습니다.
AEye, Inc. (Nasdaq : LIDR) a déposé l'amendement n° 4 à son prospectus 424(b)(5), élargissant son programme at-the-market (ATM) avec A.G.P./Alliance Global Partners, passant d'un total de 2,6 millions de dollars à jusqu'à 75 millions de dollars d'actions ordinaires. La société a déjà émis environ 23,7 millions de dollars dans le cadre des suppléments précédents, laissant environ 51,3 millions de dollars disponibles pour de futures ventes.
Au 25 juillet 2025, le flottant public d'AEye s'élève à 129,7 millions de dollars (29,28 millions d'actions non affiliées à 4,43 dollars chacune), dépassant ainsi le seuil de 75 millions de dollars ; par conséquent, les limitations du formulaire S-3 I.B.6 sur les offres incrémentales ne s'appliquent plus. Le dépôt réaffirme qu'AEye est une entreprise en croissance émergente et une société à plus petite capitalisation, mettant en avant le langage habituel relatif aux investissements à haut risque.
L'amendement accroît la flexibilité de levée de fonds, améliorant potentiellement la liquidité mais introduisant également un risque de dilution pour les actionnaires existants, car des actions supplémentaires pourraient être émises au prix du marché.
AEye, Inc. (Nasdaq: LIDR) hat Änderungsantrag Nr. 4 zu seinem 424(b)(5)-Prospekt eingereicht und sein At-the-Market-(ATM)-Programm mit A.G.P./Alliance Global Partners von insgesamt 2,6 Millionen US-Dollar auf bis zu 75 Millionen US-Dollar an Stammaktien ausgeweitet. Das Unternehmen hat bereits etwa 23,7 Millionen US-Dollar unter vorherigen Nachträgen ausgegeben, wodurch noch rund 51,3 Millionen US-Dollar für zukünftige Verkäufe verfügbar sind.
Zum 25. Juli 2025 beträgt der öffentliche Streubesitz von AEye 129,7 Millionen US-Dollar (29,28 Mio. nicht verbundene Aktien zu je 4,43 USD), womit die Schwelle von 75 Millionen US-Dollar überschritten ist; daher gelten die Form S-3 I.B.6-Beschränkungen für zusätzliche Angebote nicht mehr. Die Einreichung bestätigt, dass AEye ein wachsendes, kleineres berichtspflichtiges Unternehmen ist und hebt die üblichen Hinweise auf hohe Investitionsrisiken hervor.
Die Änderung erhöht die Flexibilität bei der Kapitalbeschaffung, was die Liquidität potenziell verbessert, aber auch ein Verwässerungsrisiko für bestehende Aktionäre mit sich bringt, da zusätzliche Aktien zum Marktpreis ausgegeben werden können.
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-274546
AMENDMENT NO. 4 DATED JULY 28, 2025
To Prospectus Supplements dated December 30, 2024 and September 13, 2024
(To Prospectus dated September 15, 2023)
AEYE, INC.
Up to $75,000,000
Common Stock
This Amendment No. 4 to the Prospectus Supplements (the “Amendment”) amends and supplements the information in the prospectus, dated September 15, 2023 (the “Prospectus”), filed with the Securities and Exchange Commission as a part of our registration statement on Form S-3 (File No. 333-274546) (the “Registration Statement”), as previously supplemented by our prospectus supplements, dated September 13, 2024 and December 30, 2024, as amended by Amendment No. 1, dated January 7, 2025, Amendment No. 2, dated January 23, 2025, and Amendment No. 3, dated July 25, 2025 (collectively, the “Prospectus Supplements,” and together with the Prospectus, the “Prior Prospectus”), relating to the offer and sale of shares of our common stock having an aggregate offering price of up to $2,600,000 pursuant to the terms of At Market Issuance Sales Agreement, dated September 12, 2024 (the “Sales Agreement”), with A.G.P./Alliance Global Partners (“A.G.P.”). This Amendment should be read in conjunction with the Prior Prospectus, and is qualified by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the Prior Prospectus. This Amendment is not complete without, and may only be delivered or utilized in connection with, the Prior Prospectus and any future amendments or supplements thereto.
We are filing this Amendment to amend the Prior Prospectus to update the maximum amount of shares that we are eligible to sell under our Prospectus Supplements pursuant to the Sales Agreement. We are increasing the amount of shares of our common stock we may offer and sell from time to time under our Prospectus Supplements through A.G.P to an aggregate offering price of up to $75,000,000, which includes the shares of our common stock having an aggregate gross sales price of approximately $23,724,958 that were sold pursuant to the Prior Prospectus to date. This Amendment amends and/or supplements only those sections of the Prior Prospectus as listed in this Amendment, and all other sections of the Prior Prospectus remain as is.
As of July 25, 2025, the aggregate market value of our outstanding shares of common stock held by non-affiliates, or public float, was determined to be $129,700,401 based on 30,316,365 shares of common stock outstanding, of which 29,277,743 are held by non-affiliates, and at a price of $4.43 per share, the closing price of our common stock on July 25, 2025. As a result, our public float has increased above $75.0 million, and we are no longer subject to the limitations contained in General Instruction I.B.6 of Form S-3 as of the date of this Amendment. If we become subject to the offering limits in General Instruction I.B.6 of Form S-3 in the future, we will file another amendment or prospectus supplement.
We are an “emerging growth company” and “smaller reporting company” as defined under U.S. federal securities laws and are subject to reduced public company reporting requirements. Our common stock is listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “LIDR.” The last sale price of our common stock, as reported on Nasdaq on July 25, 2025, was $4.43 per share.
Investing in our common stock involves a high degree of risk. See the “Risk Factors” section beginning on page S-6 of the Prospectus Supplement dated September 13, 2024 and the documents incorporated by reference into this Amendment and the Prior Prospectus, as they may be amended, updated or supplemented periodically in our reports filed with the Securities and Exchange Commission, before investing in our common stock.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this Amendment or the Prior Prospectus are truthful or complete. Any representation to the contrary is a criminal offense.
A.G.P.
The date of this Amendment No. 4 to the Prospectus Supplements is July 28, 2025
FAQ
How much additional capital can AEye (LIDR) now raise under its ATM program?
Why is AEye no longer subject to Form S-3 Instruction I.B.6 limits?
What is the latest market price used in the filing?
How many shares are currently outstanding and held by non-affiliates?
What are the risks highlighted in the amendment?
